HTG Molecular Diagnostics, Inc. (HTGM) Financials

NASDAQ Currency in USD Disclaimer

$0.48

north_east NA Past Year
Day's range
$0.48
Day's range
$0.48

HTGM Income statement / Annual

Last year (2022), HTG Molecular Diagnostics, Inc.'s total revenue was $6.37 M, a decrease of 28.52% from the previous year. In 2022, HTG Molecular Diagnostics, Inc.'s net income was -$21.59 M. See HTG Molecular Diagnostics, Inc.�s key income statements, including revenue, expenses, profit, and income.

Period FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014 FY-2013
Period Ended 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013
Operating Revenue $6.37 M $8.91 M $8.55 M $19.20 M $21.50 M $14.76 M $5.13 M $4.04 M $3.33 M $2.24 M
Cost of Revenue $4.57 M $4.09 M $3.99 M $8.91 M $5.09 M $4.97 M $4.14 M $3.34 M $3.20 M $2.25 M
Gross Profit $1.79 M $4.81 M $4.56 M $10.29 M $16.41 M $9.79 M $996,846.00 $706,064.00 $124,042.00 -$3,826.00
Gross Profit Ratio 0.28 0.54 0.53 0.54 0.76 0.66 0.19 0.17 0.04 -0
Research and Development Expenses $6.78 M $6.09 M $6.08 M $10.57 M $12.60 M $10.00 M $7.90 M $4.60 M $3.08 M $4.20 M
General & Administrative Expenses $0.00 $0.00 $0.00 $0.00 $19.97 M $17.51 M $17.43 M $14.99 M $0.00 $0.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $15.84 M $16.55 M $18.06 M $18.68 M $19.97 M $17.51 M $17.43 M $14.99 M $0.00 $0.00
Other Expenses $8,333.00 -$1.03 M $22,268.00 $0.00 $0.00 $0.00 $0.00 $0.00 $9.90 M $7.71 M
Operating Expenses $22.62 M $22.64 M $24.14 M $29.25 M $32.57 M $27.51 M $25.33 M $19.60 M $12.97 M $11.91 M
Cost And Expenses $27.20 M $26.73 M $28.13 M $38.16 M $37.66 M $32.48 M $29.46 M $22.93 M $16.18 M $14.16 M
Interest Income $94,355.00 $29,884.00 $254,736.00 $623,355.00 $715,723.00 $73,178.00 $112,413.00 $85,859.00 $0.00 $0.00
Interest Expense $856,731.00 $1.06 M $1.02 M $957,535.00 $901,820.00 $1.31 M $1.87 M $1.72 M $706,866.00 $211,872.00
Depreciation & Amortization $689,826.00 -$1.74 M $1.62 M $2.36 M $1.47 M $1.24 M $1.47 M $662,562.00 $496,595.00 $315,086.00
EBITDA -$20.14 M -$19.56 M -$17.96 M -$16.60 M -$14.08 M -$16.41 M -$22.69 M -$19.01 M -$12.75 M -$11.24 M
EBITDA Ratio -3.16 -2.2 -2.1 -0.86 -0.65 -1.11 -4.42 -4.7 -3.83 -5.01
Operating Income Ratio -3.27 -2 -2.29 -0.99 -0.75 -1.2 -4.74 -4.67 -3.86 -5.31
Total Other Income/Expenses Net -$754,043.00 $701,131.00 -$1.27 M -$334,180.00 -$291,161.00 -$1.23 M -$1.70 M -$2.50 M -$1.11 M $146,047.00
Income Before Tax -$21.58 M -$17.12 M -$20.86 M -$19.29 M -$16.45 M -$18.96 M -$26.03 M -$21.39 M -$13.96 M -$11.77 M
Income Before Tax Ratio -3.39 -1.92 -2.44 -1 -0.76 -1.28 -5.07 -5.29 -4.19 -5.25
Income Tax Expense $10,837.00 $22,475.00 $14,415.00 $3,379.00 $3,526.00 $2,921.00 $10,118.00 $10,189.00 -$402,683.00 $357,919.00
Net Income -$21.59 M -$17.15 M -$20.87 M -$19.30 M -$16.45 M -$18.96 M -$26.04 M -$21.40 M -$13.96 M -$11.77 M
Net Income Ratio -3.39 -1.92 -2.44 -1 -0.77 -1.28 -5.07 -5.29 -4.19 -5.25
EPS -24.28 -29.66 -54.12 -91.17 -0.75 -2.24 -4.58 -5.92 -52.33 -44.13
EPS Diluted -24.28 -29.66 -54.12 -91.17 -0.75 -2.24 -4.58 -5.92 -5.95 -44.13
Weighted Average Shares Out $889,284.00 $578,011.00 $385,659.00 $211,664.00 $22.02 M $8.48 M $5.69 M $3.61 M $266,724.00 $266,724.00
Weighted Average Shares Out Diluted $889,284.00 $578,011.00 $385,659.00 $211,664.00 $22.02 M $8.48 M $5.69 M $3.61 M $2.35 M $266,724.00
Link